Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

107.78
Delayed Data
As of Apr 20
 -3.96 / -3.54%
Today’s Change
96.18
Today|||52-Week Range
149.34
-9.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line170.0M165.0M78.0M30.3M
 
 
 
 
 
Depreciation99.0M102.0M103.0M183.5M
 
 
 
 
 
Total Other Cash Flow56.0M105.0M152.0M88.2M
 
 
 
 
 
Funds From Operations324.0M395.0M254.0M313.1M
 
 
 
 
 
Funds From/For Other Operating Expenses16.0M115.0M-16.0M55.5M
 
 
 
 
 
Net Cash Flow - Operating Activities308.0M280.0M270.0M257.6M
 
 
 
 
 
 
InvestingIncrease In Investments-703.0M-430.0M-455.0M-70.7M
 
 
 
 
 
Decrease In Investments283.0M275.0M374.0M165.6M
 
 
 
 
 
Capital Expenditures-75.0M-100.0M-94.0M-88.3M
 
 
 
 
 
Other Investing - Sources0.002.0M4.0M-5.9M
 
 
 
 
Net Cash Flow Investing-495.0M-253.0M-171.0M700.0K
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction-44.0M-52.0M-45.0M-34.0M
 
 
 
 
 
Net Proceeds Stock Sale47.0M13.0M16.0M9.9M
 
 
 
 
 
Common Preferred Redeemed-68.0M-171.0M-60.0M-164.6M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing----------
Other Uses - Financing4.0M-3.0M6.0M36.9M
 
 
 
 
 
Net Cash Flow - Financing-69.0M-207.0M-95.0M-225.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash3.0M9.0M4.0M1.7M
 
 
 
 
 
 
Net Change In Cash-256.0M-180.0M4.0M32.7M